سعر فيكسامود Vexamod‏ 150مجم 10 كبسولات 2026

Venlafaxine 150 mg extended-release capsules, a serotonin-norepinephrine reuptake inhibitor antidepressant, marketed in Egypt by Sigma.

• Most common (>=5% and at least twice placebo): nausea, somnolence, dry mouth, sweating, abnormal ejaculation, anorexia, constipation, impotence and decreased libido.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to venlafaxine, desvenlafaxine or excipients; use with, or within 14 days of stopping, an MAOI (including linezolid or IV methylene blue) because of serotonin syndrome risk.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: increased risk of suicidal thoughts and behaviours in children, adolescents and young adults; monitor for clinical worsening.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Serotonin syndrome, elevated blood pressure (control hypertension first and monitor), increased bleeding risk with antiplatelets/anticoagulants/NSAIDs, angle-closure glaucoma, mania activation, discontinuation syndrome, seizures and hyponatraemia.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Monoamine oxidase inhibitorsContraindicated: increased risk of serotonin syndrome.DailyMed (U.S. National Library of Medicine)
• Other serotonergic drugs (SSRIs, SNRIs, triptans, tramadol, etc.)Increased risk of serotonin syndrome; monitor.DailyMed (U.S. National Library of Medicine)

• Observational data associate SNRI exposure, particularly in the month before delivery, with a less than 2-fold increase in postpartum haemorrhage risk.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Venlafaxine and its active metabolite are present in human milk; no adverse reactions in breastfed infants were shown in published data.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Venlafaxine: Potent inhibitor of neuronal serotonin and norepinephrine reuptake; weak dopamine reuptake inhibitor.